Axonics Modulation Technologies Financials

Axonics Modulation Stock Summary

Axonics Modulation competes with Orthofix Medical, Glaukos Corp, Bruker, Integer Holdings, and CONMED. Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation systems. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. Axonics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 517 people.

Axonics Modulation Key Financial Ratios

Axonics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Axonics Modulation's current stock value. Our valuation model uses many indicators to compare Axonics Modulation value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axonics Modulation competition to find correlations between indicators driving Axonics Modulation's intrinsic value. More Info.Axonics Modulation Technologies is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axonics Modulation's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.